Dudediligence.

PAVmed Inc

PAVMNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

6.27M

on 2026-06-30, from 295K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-30 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$125.0M

S-3 of 2024-12-20. 3 prospectus supplements filed under it since. S-3 ↗

$9.4M

A.G.P./Alliance Global Partners, agreement of 2026-09-10. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-13 is not read yet.

Cash

2 quarters

$3.8M on 2026-06-30 ÷ $1.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-02-03Private placement100not read$30.0M8-K ↗
2025-02-18Private placement incl. 0.76M pre-funded1,513,468$0.7115not stated8-K ↗
2024-11-20Private placement2,653$1000.00not stated8-K ↗

Also on file: a 1-for-10 reverse split, 2026-01-02 8-K ↗